TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 2.57nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 2.90nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 4.70nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 5.40nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 5.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 5.70nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: 6nMAssay Description:Inhibition of recombinant CP1-CCP2-SP fragment of MASP-2 (unknown origin)More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 6.80nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 6.90nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.40nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 7.90nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 9.30nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 9.5nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 24nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 37.5nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of human MASP-2 (287 to 686 residues) using Z-Lys-SBzl as substrate incubated for 1 hr by plate reader based analysisMore data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: <50nMAssay Description:The MASP-2 assay protocol was carried out as follows. Test compounds were serially diluted in DMSO and then 100 nL of each dilution was transferred t...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: <50nMAssay Description:The MASP-2 assay protocol was carried out as follows. Test compounds were serially diluted in DMSO and then 100 nL of each dilution was transferred t...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: <50nMAssay Description:The MASP-2 assay protocol was carried out as follows. Test compounds were serially diluted in DMSO and then 100 nL of each dilution was transferred t...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: <50nMAssay Description:The MASP-2 assay protocol was carried out as follows. Test compounds were serially diluted in DMSO and then 100 nL of each dilution was transferred t...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataKi: <50nMAssay Description:The MASP-2 assay protocol was carried out as follows. Test compounds were serially diluted in DMSO and then 100 nL of each dilution was transferred t...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 62nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair
TargetMannan-binding lectin serine protease 2(Human)
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Innoviva Specialty Therapeutics, Inc.
Curated by ChEMBL
Affinity DataIC50: 63.5nMAssay Description:Recombinant human MASP2 enzyme produced in the HEK 293 cells was diluted in the reaction buffer (50 mM HEPES pH 8,0; 100 mM NaCl; 0,01% CHAPS; 0.5 mM...More data for this Ligand-Target Pair

















































